Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 29% ± 13% | |
non-classical monocyte | 3 studies | 19% ± 4% | |
ciliated cell | 3 studies | 28% ± 8% | |
GABAergic neuron | 3 studies | 33% ± 10% | |
glutamatergic neuron | 3 studies | 44% ± 9% | |
dendritic cell | 3 studies | 26% ± 5% | |
plasmacytoid dendritic cell | 3 studies | 23% ± 8% | |
astrocyte | 3 studies | 26% ± 5% | |
oligodendrocyte | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1220.86 | 1445 / 1445 | 100% | 21.87 | 183 / 183 |
ovary | 100% | 2243.71 | 180 / 180 | 100% | 17.24 | 430 / 430 |
breast | 100% | 1270.66 | 459 / 459 | 100% | 26.06 | 1117 / 1118 |
lung | 100% | 1031.03 | 577 / 578 | 100% | 21.41 | 1155 / 1155 |
uterus | 100% | 1510.69 | 170 / 170 | 100% | 22.71 | 458 / 459 |
thymus | 100% | 1210.09 | 653 / 653 | 99% | 18.11 | 601 / 605 |
brain | 99% | 1123.92 | 2626 / 2642 | 100% | 16.25 | 704 / 705 |
prostate | 100% | 1229.05 | 245 / 245 | 99% | 17.64 | 498 / 502 |
bladder | 100% | 1406.90 | 21 / 21 | 99% | 20.71 | 497 / 504 |
stomach | 100% | 934.52 | 359 / 359 | 98% | 19.37 | 281 / 286 |
intestine | 100% | 1499.93 | 966 / 966 | 98% | 19.05 | 515 / 527 |
pancreas | 99% | 635.50 | 324 / 328 | 99% | 15.87 | 176 / 178 |
adrenal gland | 100% | 1132.72 | 258 / 258 | 97% | 16.21 | 224 / 230 |
liver | 100% | 652.46 | 225 / 226 | 97% | 9.89 | 392 / 406 |
kidney | 100% | 901.71 | 89 / 89 | 96% | 11.96 | 865 / 901 |
skin | 100% | 1291.80 | 1805 / 1809 | 93% | 17.78 | 437 / 472 |
blood vessel | 100% | 1161.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.31 | 29 / 29 |
muscle | 100% | 1709.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1431.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.39 | 1 / 1 |
adipose | 100% | 1129.21 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 885.47 | 821 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 921.87 | 778 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 54% | 5.38 | 43 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050821 | Biological process | protein stabilization |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0005829 | Cellular component | cytosol |
GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
GO_0097255 | Cellular component | R2TP complex |
GO_0005515 | Molecular function | protein binding |
Gene name | RPAP3 |
Protein name | RNA polymerase II-associated protein 3 |
Synonyms | |
Description | FUNCTION: Forms an interface between the RNA polymerase II enzyme and chaperone/scaffolding protein, suggesting that it is required to connect RNA polymerase II to regulators of protein complex formation. . |
Accessions | ENST00000380650.4 [Q9H6T3-2] Q9H6T3 ENST00000432584.7 [Q9H6T3-3] ENST00000005386.8 [Q9H6T3-1] |